\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ laboratory\\ data\\:\ \(0\)\
\-\ wbc\\:\\ 5\\.4\\,\\ hgb\\:\\ 11\\.0\\,\\ hct\\:\\ 33\\.6\\,\\ plts\\:\\ 309\\.\ \(0\)\
\-\ further\\ in\\ the\\ hospitalization\\:\ \(0\)\
\-\ ldh\\:\\ 506\\ u\\/l\ \(0\)\
\-\ gram\\ stain\\:\\ few\\ rbcs\\,\\ no\\ organisms\\ noted\\.\ \(0\)\
\-\ afb\\:\\ negative\ \(0\)\
\-\ pneumocystis\\ direct\\ fluorescent\\ antibody\\ \\(dfa\\)\\:\\ negative\\ \ \(0\)\
\-\ c\\.\\ neoformans\\:\\ negative\ \(0\)\
\-\ legionella\\:\\ negative\ \(0\)\
\-\ s\\.\\ pneumonia\\:\\ negative\ \(0\)\
\-\ hiv\\:\\ positive\ \(0\)\
\-\ cd4\\/cd8\\ ratio\\:\\ 0\\.55\\ l\\ \\(0\\.79\\-4\\.39\\)\ \(0\)\
\-\ abs\\ cd3\\/cd4\\:\\ 144\\ l\\ \\(414\\-1293\\ cell\\/ul\\)\ \(0\)\
\-\ abs\\ cd3\\:\\ 413\\ l\\ \\(690\\-2540\\ cell\\/ul\\)\ \(0\)\
\-\ abs\\ cd19\\+\\:\\ 51\\ l\\ \\(90\\-660\\ cell\\/ul\\)\ \(0\)\
\-\ the\\ lingular\\ biopsy\\ specimen\\ demonstrated\\ diffuse\\ alveolar\\ damage\\,\\ with\\ an\\ organizing\\ fibrosing\\ pattern\\.\\ \\ the\\ anterior\\ segment\\ of\\ the\\ left\\ upper\\ lobe\\ specimen\\ revealed\\ marked\\ interstitial\\ fibrosis\\,\\ focal\\ type\\ ii\\ pneumocyte\\ hyperplasia\\,\\ squamous\\ metaplasia\\,\\ and\\ scattered\\ residual\\ alveoli\\ consistent\\ with\\ organizing\\ to\\ fibrosing\\ pattern\\ of\\ diffuse\\ alveolar\\ damage\\.\\ \\ the\\ typical\\ histologic\\ findings\\ of\\ pcp\\ consist\\ of\\ proliferation\\ of\\ type\\ ii\\ pneumocytes\\,\\ diffuse\\ alveolar\\ damage\\,\\ granulomatous\\ inflammation\\,\\ and\\ cyst\\ formation\\.\ \(0\)\
\-\ open\\ lung\\ biopsy\\ demonstrated\\ the\\ histologic\\ findings\\ of\\ pneumocystis\\ jiroveci\\,\\ and\\ the\\ gms\\ stain\\ was\\ positive\\,\\ confirming\\ the\\ suspected\\ diagnosis\\ of\\ pneumocystis\\ jiiroveci\\ pneumonia\\.\ \(0\)\
\-\ admission\\ radiography\\:\\ \\ pa\\ chest\\ radiograph\\ reveals\\ a\\ right\\ subclavian\\ central\\ venous\\ catheter\\ with\\ hypoinflated\\ lung\\ volumes\\ and\\ increased\\ bibasilar\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ contrast\\ enhanced\\ ct\\ on\\ admission\\:\\ \\ diffuse\\ multilobar\\ ground\\-glass\\ opacities\\ with\\ sharp\\ transitions\\ between\\ normal\\ and\\ abnormal\\ lung\\,\\ with\\ interstitial\\ thickening\\ in\\ a\\ predominately\\ lower\\-lobe\\ distribution\\.\ \(0\)\
\-\ hospital\\ day\\ 2\\:\\ \\ ap\\ chest\\ radiograph\\ demonstrates\\ a\\ stable\\ right\\ subclavian\\ venous\\ catheter\\,\\ with\\ bibasilar\\ reticulonodular\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ hospital\\ day\\ 6\\:\\ ap\\ chest\\ radiograph\\ from\\ hospital\\ day\\ 6\\,\\ reveals\\ that\\ the\\ patient\\ has\\ been\\ intubated\\,\\ and\\ has\\ developed\\ a\\ spontaneous\\ pneumomediastinum\\ with\\ extensive\\ subcutaneous\\ emphysema\\ surrounding\\ the\\ neck\\.\\ \\ there\\ is\\ no\\ pneumothorax\\.\\ \\ there\\ are\\ continued\\ bibasilar\\ reticulonodular\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ ap\\ chest\\ radiograph\\ from\\ hospital\\ day\\ 6\\,\\ obtained\\ later\\ in\\ the\\ day\\ secondary\\ to\\ new\\ respiratory\\ distress\\,\\ reveals\\ that\\ the\\ patient\\ has\\ developed\\ a\\ significant\\ left\\ sided\\ pneumothorax\\,\\ with\\ persistent\\ pneumomediastinum\\,\\ bibasilar\\ ground\\-glass\\ reticulonodular\\ opacities\\,\\ and\\ subcutaneous\\ emphysema\\ surrounding\\ the\\ base\\ of\\ the\\ neck\\.\\ \\ the\\ patient\\â\\€\\™s\\ support\\ devices\\ are\\ stable\\ when\\ compared\\ to\\ the\\ prior\\ studies\\.\ \(0\)\
\-\ on\\ hospital\\ day\\ 10\\ the\\ patient\\ experienced\\ worsening\\ respiratory\\ distress\\,\\ and\\ an\\ unenhanced\\ ct\\ of\\ the\\ chest\\ was\\ performed\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ aortic\\ arch\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ is\\ a\\ small\\ right\\-sided\\ pleural\\ effusion\\,\\ with\\ persistent\\ ground\\-glass\\ opacities\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ hila\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ are\\ persistent\\ ground\\-glass\\ opacities\\ with\\ focal\\ areas\\ of\\ consolidation\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ right\\ hemidiaphragm\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ are\\ persistent\\ ground\\-glass\\ opacities\\ with\\ focal\\ areas\\ of\\ consolidation\\,\\ and\\ a\\ small\\ right\\-sided\\ pleural\\ effusion\\.\ \(0\)\
\-\ pneumocystis\\ jiroveci\\ \\(p\\.\\ carinii\\)\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ pneumocystis\\ jiroveci\\ pneumonia\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cmv\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ lymphocytic\\ interstitial\\ pneumonia\\.\ \(0\)\
\-\ 60\\ year\\ old\\ male\\ with\\ tachypnea\\ and\\ tachycardia\\ with\\ high\\ clinical\\ concern\\ for\\ pulmonary\\ embolus\\.\ \(1\)\
\-\ this\\ case\\ demonstrates\\ typical\\ radiographic\\ findings\\ of\\ pcp\\,\\ with\\ symmetric\\ bilateral\\ lower\\ lobe\\ reticulonodular\\ opacities\\,\\ complicated\\ by\\ pneumomediastinum\\ followed\\ by\\ the\\ development\\ of\\ pneumothorax\\.\\ \\ additionally\\,\\ the\\ bal\\ was\\ negative\\,\\ necessitating\\ open\\ lung\\ biopsy\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ opacities\\:\\ 0\\.06813121625720231\ \(0\)\
\-\ pneumomediastinum\\:\\ 0\\.05418347228353159\ \(0\)\
\-\ pneumocystis\\:\\ 0\\.05306085794995723\ \(0\)\
\-\ ground\\-glass\\:\\ 0\\.05184607999035898\ \(0\)\
\-\ cell\\/ul\\:\\ 0\\.044900772957384545\ \(0\)\
\-\ \\:\\:\\ 0\\.042217395503895805\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.041038571828364796\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.04086414987334372\ \(0\)\
\-\ abs\\:\\ 0\\.039305124628005374\ \(0\)\
\-\ bibasilar\\:\\ 0\\.037485103958996055\ \(0\)\
\-\ pneumonia\\:\\ 0\\.035982832209458505\ \(0\)\
\-\ jiroveci\\:\\ 0\\.03577466360647764\ \(0\)\
\-\ day\\:\\ 0\\.02763626311734733\ \(0\)\
\-\ hospital\\:\\ 0\\.027309817189882204\ \(0\)\
\-\ l\\:\\ 0\\.02645526314525211\ \(0\)\
\-\ negative\\:\\ 0\\.025997828469014002\ \(0\)\
\-\ alveolar\\:\\ 0\\.025986144434272617\ \(0\)\
\-\ glass\\:\\ 0\\.025183280541894438\ \(0\)\
\-\ continued\\:\\ 0\\.024989609418785984\ \(0\)\
\-\ ground\\:\\ 0\\.023962535958199596\ \(0\)\
\-\ damage\\:\\ 0\\.023261578176148417\ \(0\)\
\-\ persistent\\:\\ 0\\.02314666657050173\ \(0\)\
\-\ organizing\\:\\ 0\\.022472984199084136\ \(0\)\
\-\ fibrosing\\:\\ 0\\.022115223534711213\ \(0\)\
\-\ left\\-sided\\:\\ 0\\.0214448976467491\ \(0\)\
\-\ interstitial\\:\\ 0\\.02129434347573954\ \(0\)\
\-\ radiograph\\:\\ 0\\.018485220060586505\ \(0\)\
\-\ histologic\\:\\ 0\\.0183847913151251\ \(0\)\
\-\ pcp\\:\\ 0\\.0183847913151251\ \(0\)\
\-\ stain\\:\\ 0\\.017861359465117434\ \(0\)\
\-\ diffuse\\:\\ 0\\.01756881100424662\ \(0\)\
\-\ specimen\\:\\ 0\\.01740794217267423\ \(0\)\
\-\ chest\\:\\ 0\\.017357631579435644\ \(0\)\
\-\ reveals\\:\\ 0\\.01702842657196107\ \(0\)\
\-\ lung\\:\\ 0\\.016809230018599294\ \(0\)\
\-\ ap\\:\\ 0\\.015917617841981858\ \(0\)\
\-\ emphysema\\:\\ 0\\.01586547944847187\ \(0\)\
\-\ demonstrates\\:\\ 0\\.015845680828974414\ \(0\)\
\-\ biopsy\\:\\ 0\\.015441561502394367\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.015097013825125558\ \(0\)\
\-\ 309\\.\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ 506\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ cd4\\/cd8\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ 0\\.79\\-4\\.39\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ cd3\\/cd4\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ 414\\-1293\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ 690\\-2540\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ 90\\-660\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ pneumocyte\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ pneumocytes\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ jiiroveci\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ transitions\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ lower\\-lobe\\:\\ 0\\.01496692431912818\ \(0\)\
\-\ subclavian\\:\\ 0\\.014808730484594194\ \(0\)\
\-\ \\,\\:\\ 0\\.01470750780399524\ \(0\)\
\-\ consolidation\\:\\ 0\\.014543018440791993\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.014163421136927421\ \(0\)\
\-\ catheter\\:\\ 0\\.013942235051457265\ \(0\)\
\-\ 33\\.6\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ fluorescent\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ 0\\.55\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ 413\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ cd19\\+\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ multilobar\\:\\ 0\\.013790103978618936\ \(0\)\
\-\ image\\:\\ 0\\.013595190999818001\ \(0\)\
\-\ dfa\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ neoformans\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ cd3\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ gms\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ hypoinflated\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ bal\\:\\ 0\\.013101708209335124\ \(0\)\
\-\ 6\\:\\ 0\\.012998914234507001\ \(0\)\
\-\ open\\:\\ 0\\.012897244778103814\ \(0\)\
\-\ admission\\:\\ 0\\.0127866295983598\ \(0\)\
\-\ level\\:\\ 0\\.01254442628682648\ \(0\)\
\-\ ii\\:\\ 0\\.012514837721709422\ \(0\)\
\-\ focal\\:\\ 0\\.012430357915815291\ \(0\)\
\-\ axial\\:\\ 0\\.012421688333113098\ \(0\)\
\-\ distress\\:\\ 0\\.01222608715231753\ \(0\)\
\-\ respiratory\\:\\ 0\\.012046384600689882\ \(0\)\
\-\ stable\\:\\ 0\\.01195997826567744\ \(0\)\
\-\ typical\\:\\ 0\\.01163479352852291\ \(0\)\
\-\ 5\\.4\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ plts\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ legionella\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ 144\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ metaplasia\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ alveoli\\:\\ 0\\.011436463297600445\ \(0\)\
\-\ pleural\\:\\ 0\\.011267742610096082\ \(0\)\
\-\ 11\\.0\\:\\ 0\\.011236492099542068\ \(0\)\
\-\ carinii\\:\\ 0\\.011236492099542068\ \(0\)\
\-\ developed\\:\\ 0\\.011171699439167111\ \(0\)\
\-\ pattern\\:\\ 0\\.011091485022313339\ \(0\)\
\-\ necessitating\\:\\ 0\\.011057611767355606\ \(0\)\
\-\ effusion\\:\\ 0\\.011026057454008153\ \(0\)\
\-\ lingular\\:\\ 0\\.010895794823714987\ \(0\)\
\-\ hila\\:\\ 0\\.010895794823714987\ \(0\)\
\-\ there\\:\\ 0\\.010795548017529615\ \(0\)\
\-\ venous\\:\\ 0\\.010532379010041185\ \(0\)\
\-\ rbcs\\:\\ 0\\.010369215998071796\ \(0\)\
\-\ devices\\:\\ 0\\.010369215998071796\ \(0\)\
\-\ afb\\:\\ 0\\.010156714906469069\ \(0\)\
\-\ an\\:\\ 0\\.010031110902247283\ \(0\)\
\-\ type\\:\\ 0\\.009781406547867268\ \(0\)\
\-\ areas\\:\\ 0\\.009763487848034182\ \(0\)\
\-\ volumes\\:\\ 0\\.009718974483205743\ \(0\)\
\-\ antibody\\:\\ 0\\.0096435045976865\ \(0\)\
\-\ p\\.\\:\\ 0\\.00957124718780739\ \(0\)\
\-\ surrounding\\:\\ 0\\.00953876150887866\ \(0\)\
\-\ positive\\:\\ 0\\.009415570764971534\ \(0\)\
\-\ consist\\:\\ 0\\.009371275989749014\ \(0\)\
\-\ predominately\\:\\ 0\\.009309531262803554\ \(0\)\
\-\ cmv\\:\\ 0\\.009309531262803554\ \(0\)\
\-\ findings\\:\\ 0\\.009264025139846994\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.009249953470254708\ \(0\)\
\-\ confirming\\:\\ 0\\.00919239565756255\ \(0\)\
\-\ ldh\\:\\ 0\\.009082822616581955\ \(0\)\
\-\ hospitalization\\:\\ 0\\.009030578713921931\ \(0\)\
\-\ gram\\:\\ 0\\.008979894565959825\ \(0\)\
\-\ unenhanced\\:\\ 0\\.008930679732558717\ \(0\)\
\-\ u\\/l\\:\\ 0\\.008836333635521687\ \(0\)\
\-\ organisms\\:\\ 0\\.008791056475789665\ \(0\)\
\-\ proliferation\\:\\ 0\\.00874695548019839\ \(0\)\
\-\ embolus\\:\\ 0\\.00874695548019839\ \(0\)\
\-\ intubated\\:\\ 0\\.008621135493519744\ \(0\)\
\-\ tachypnea\\:\\ 0\\.008621135493519744\ \(0\)\
\-\ neck\\:\\ 0\\.008520350210589075\ \(0\)\
\-\ demonstrated\\:\\ 0\\.00851415953296084\ \(0\)\
\-\ s\\.\\:\\ 0\\.008503999888278742\ \(0\)\
\-\ hemidiaphragm\\:\\ 0\\.008430171175308048\ \(0\)\
\-\ c\\.\\:\\ 0\\.008394426847298145\ \(0\)\
\-\ radiography\\:\\ 0\\.008258530908972954\ \(0\)\
\-\ tachycardia\\:\\ 0\\.008258530908972954\ \(0\)\
\-\ has\\:\\ 0\\.008173344501668648\ \(0\)\
\-\ hgb\\:\\ 0\\.008073133129745466\ \(0\)\
\-\ hiv\\:\\ 0\\.008044110322683835\ \(0\)\
\-\ ratio\\:\\ 0\\.008044110322683835\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.007981397376549515\ \(0\)\
\-\ are\\:\\ 0\\.007910858217518517\ \(0\)\
\-\ hct\\:\\ 0\\.007879679378728117\ \(0\)\
\-\ 51\\:\\ 0\\.007879679378728117\ \(0\)\
\-\ data\\:\\ 0\\.007853758373412687\ \(0\)\
\-\ sharp\\:\\ 0\\.007853758373412687\ \(0\)\
\-\ lobe\\:\\ 0\\.007807556359672441\ \(0\)\
\-\ support\\:\\ 0\\.007778288487893444\ \(0\)\
\-\ experienced\\:\\ 0\\.0075271507458278715\ \(0\)\
\-\ complicated\\:\\ 0\\.0075271507458278715\ \(0\)\
\-\ confirm\\:\\ 0\\.007384737360461654\ \(0\)\
\-\ \\(\\:\\ 0\\.007358523527102145\ \(0\)\
\-\ \\)\\:\\ 0\\.0072686352337518354\ \(0\)\
\-\ concern\\:\\ 0\\.0072176065067889005\ \(0\)\
\-\ residual\\:\\ 0\\.007200012640854186\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.007148299215583033\ \(0\)\
\-\ squamous\\:\\ 0\\.007098114491913179\ \(0\)\
\-\ granulomatous\\:\\ 0\\.007001987337414864\ \(0\)\
\-\ direct\\:\\ 0\\.006852962531162935\ \(0\)\
\-\ spontaneous\\:\\ 0\\.0067694476853381955\ \(0\)\
\-\ scattered\\:\\ 0\\.00675591938372669\ \(0\)\
\-\ a\\:\\ 0\\.0067334431548149625\ \(0\)\
\-\ small\\:\\ 0\\.00668446616088665\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006662883975485296\ \(0\)\
\-\ symmetric\\:\\ 0\\.006626253884941335\ \(0\)\
\-\ few\\:\\ 0\\.006529210737505089\ \(0\)\
\-\ distribution\\:\\ 0\\.006529210737505089\ \(0\)\
\-\ arch\\:\\ 0\\.006529210737505089\ \(0\)\
\-\ fibrosis\\:\\ 0\\.006459903446299223\ \(0\)\
\-\ the\\:\\ 0\\.006337403543290147\ \(0\)\
\-\ segment\\:\\ 0\\.006329239539446713\ \(0\)\
\-\ 60\\:\\ 0\\.006329239539446713\ \(0\)\
\-\ development\\:\\ 0\\.006318791550356088\ \(0\)\
\-\ additionally\\:\\ 0\\.006287827904261384\ \(0\)\
\-\ suspected\\:\\ 0\\.006247402354696496\ \(0\)\
\-\ enhanced\\:\\ 0\\.00620791701995241\ \(0\)\
\-\ inflammation\\:\\ 0\\.006169329157341958\ \(0\)\
\-\ compared\\:\\ 0\\.006140953128524062\ \(0\)\
\-\ pa\\:\\ 0\\.0060675236144428785\ \(0\)\
\-\ formation\\:\\ 0\\.005988542263619632\ \(0\)\
\-\ at\\:\\ 0\\.005896926075543122\ \(0\)\
\-\ aortic\\:\\ 0\\.005872550338360757\ \(0\)\
\-\ patient\\:\\ 0\\.005817262688736081\ \(0\)\
\-\ extensive\\:\\ 0\\.005801962177332335\ \(0\)\
\-\ worsening\\:\\ 0\\.005712190102548044\ \(0\)\
\-\ base\\:\\ 0\\.005683290802769723\ \(0\)\
\-\ marked\\:\\ 0\\.005661934636034816\ \(0\)\
\-\ radiographic\\:\\ 0\\.0055065609368229775\ \(0\)\
\-\ studies\\:\\ 0\\.005418507500473955\ \(0\)\
\-\ sided\\:\\ 0\\.0053642217540690075\ \(0\)\
\-\ laboratory\\:\\ 0\\.005346505493809959\ \(0\)\
\-\ wbc\\:\\ 0\\.0052887518685497655\ \(0\)\
\-\ later\\:\\ 0\\.005238401767390363\ \(0\)\
\-\ obtained\\:\\ 0\\.005157667403639799\ \(0\)\
\-\ new\\:\\ 0\\.005055667193209776\ \(0\)\
\-\ was\\:\\ 0\\.005033671590222514\ \(0\)\
\-\ that\\:\\ 0\\.005011819112254069\ \(0\)\
\-\ thickening\\:\\ 0\\.004917868539377507\ \(0\)\
\-\ 10\\:\\ 0\\.004890703273933634\ \(0\)\
\-\ followed\\:\\ 0\\.00486396582577041\ \(0\)\
\-\ by\\:\\ 0\\.00483148014684168\ \(0\)\
\-\ initial\\:\\ 0\\.004807439971611729\ \(0\)\
\-\ central\\:\\ 0\\.00477356766869263\ \(0\)\
\-\ revealed\\:\\ 0\\.004656152614373673\ \(0\)\
\-\ further\\:\\ 0\\.004613657286587874\ \(0\)\
\-\ between\\:\\ 0\\.004598464407851008\ \(0\)\
\-\ right\\:\\ 0\\.004592351659306028\ \(0\)\
\-\ clinical\\:\\ 0\\.004464023429653657\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.004336208386494832\ \(0\)\
\-\ from\\:\\ 0\\.004300291046364048\ \(0\)\
\-\ pulmonary\\:\\ 0\\.004238625314465303\ \(0\)\
\-\ s\\:\\ 0\\.004160895869464494\ \(0\)\
\-\ when\\:\\ 0\\.0041550615239660535\ \(0\)\
\-\ abnormal\\:\\ 0\\.004137677827359782\ \(0\)\
\-\ ct\\:\\ 0\\.004058756038682659\ \(0\)\
\-\ secondary\\:\\ 0\\.004056078041610878\ \(0\)\
\-\ performed\\:\\ 0\\.004045124501234837\ \(0\)\
\-\ and\\:\\ 0\\.0039730340823749405\ \(0\)\
\-\ high\\:\\ 0\\.003970366826955544\ \(0\)\
\-\ been\\:\\ 0\\.003947020185847184\ \(0\)\
\-\ significant\\:\\ 0\\.003901268507732128\ \(0\)\
\-\ cyst\\:\\ 0\\.003898762539942449\ \(0\)\
\-\ anterior\\:\\ 0\\.0037364903629248515\ \(0\)\
\-\ prior\\:\\ 0\\.0037251490190192927\ \(0\)\
\-\ consistent\\:\\ 0\\.0035573824598152857\ \(0\)\
\-\ increased\\:\\ 0\\.0035492101558568007\ \(0\)\
\-\ bilateral\\:\\ 0\\.0035209129529956604\ \(0\)\
\-\ upper\\:\\ 0\\.0035009855778755828\ \(0\)\
\-\ noted\\:\\ 0\\.003438745651023079\ \(0\)\
\-\ lower\\:\\ 0\\.0032629237170863543\ \(0\)\
\-\ contrast\\:\\ 0\\.003247496921575391\ \(0\)\
\-\ left\\:\\ 0\\.0032465374168859583\ \(0\)\
\-\ case\\:\\ 0\\.0031740312951906123\ \(0\)\
\-\ of\\:\\ 0\\.0031647891558027417\ \(0\)\
\-\ 2\\:\\ 0\\.003124116292887175\ \(0\)\
\-\ no\\:\\ 0\\.0029217118869399048\ \(0\)\
\-\ to\\:\\ 0\\.0029002927568284294\ \(0\)\
\-\ with\\:\\ 0\\.0027810839817630838\ \(0\)\
\-\ male\\:\\ 0\\.002623438943781788\ \(0\)\
\-\ on\\:\\ 0\\.0024580339978452566\ \(0\)\
\-\ normal\\:\\ 0\\.0022743844730035673\ \(0\)\
\-\ in\\:\\ 0\\.0021463356373866978\ \(0\)\
\-\ is\\:\\ 0\\.0019093065479956726\ \(0\)\
\-\ this\\:\\ 0\\.001631811907154725\ \(0\)\
\-\ year\\:\\ 0\\.0016232687084429792\ \(0\)\
\-\ \\.\\:\\ 0\\.0015067714812116416\ \(0\)\
\-\ old\\:\\ 0\\.0014854577196303134\ \(0\)\
\-\ for\\:\\ 0\\.0012378746156922159\ \(0\)\
